NYSE ARCA | ETF
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of the Novo Nordisk A/S (B Shares) (the "Company").
The series will not invest directly in the company.
The fund is non-diversified.
Top 1 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 99.10% |